XERS
Xeris Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
XERS fundamentals
Xeris Biopharma (XERS) released its earnings on Nov 6, 2025: revenue was 74.38M (YoY +36.98%), beat estimates; EPS was 0 (YoY +100.00%), met estimates.
Revenue / YoY
74.38M
+36.98%
EPS / YoY
0
+100.00%
Report date
Nov 6, 2025
XERS Earnings Call Summary for Q3,2025
- Q3 2025 Record Revenue: $74.1M (40% YoY) with RECORLEV, Gvoke, KEVEYIS expansion.
- 2026 Phase III XP-8121: 2026 clinical trial initiation.
- 2025 EBITDA +17.4M: 2025 financial strength.
- 2026 Salesforce expansion: RECORLEV targeting GPs.
- 2025-2026 Corcept competition: Relacorilant dynamics.
- 2026 XP-8121 pipeline: R&D Phase III.
- 2025 Q3 gross margin 85%: EBITDA +17.4M.
- 2026 infrastructure scalability: 2025 Q3 40% growth, 2026 Phase III XP-8121.
- 2025 Q3 RECORLEV outperformance: 108% new patients, 2026 Phase III XP-8121.
- **2025: 40% growth, 2026 Phase III XP-8121.
- **2025 Q3: 40% growth, 2026 Phase III XP-8121.
- **2025 Q3: 40% growth, 2026 Phase III XP-8121.
- **2025 Q3: 40% growth, 2026 Phase III XP-8121.
- **2025 Q3: 40% growth, 2026 Phase III XP-8121.
EPS
Revenue
Revenue & Expenses
XERS has released its 2025 Q3 earnings report, with revenue of 74.38M, reflecting a YoY change of 37.06%, and net profit of 621.00K, showing a YoY change of 103.95%. The Sankey diagram below clearly presents XERS's revenue sources and cost distribution.
Key Indicators
Xeris Biopharma (XERS) key financial stats and ratios, covering profitability, financial health, and leverage.
Xeris Biopharma (XERS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Xeris Biopharma (XERS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Xeris Biopharma (XERS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Xeris Biopharma (XERS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Xeris Biopharma (XERS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Xeris Biopharma year over year?What guidance did Xeris Biopharma's management provide for the next earnings period?Did Xeris Biopharma beat or miss consensus estimates last quarter?What factors drove the changes in Xeris Biopharma's revenue and profit?What does Xeris Biopharma do and what are its main business segments?What is Xeris Biopharma's gross profit margin?What were the key takeaways from Xeris Biopharma’s earnings call?What were the key takeaways from Xeris Biopharma's earnings call?
